Results 31 to 40 of about 11,598 (211)
International Journal of Gynecological Pathology, 1996 Cysts maculae papillae papules plaques tumours ulcers verrucae vesicles paediatrics trauma.
Edward J. Wilkinson, I. Keith Stone
openaire +2 more sources
Complex anti-relapse therapy of various variants of the course of the vulvar lichen sclerosus: A randomized prospective study [PDF]
ГинекологияAim. To develop and evaluate the effectiveness of complex therapy of vulvar lichen sclerosus (VLS), considering the clinical and immunological variant (CIV) of the disease. Materials and methods. A randomized prospective study included 292 patients 20-
Ekaterina V. Kolesnikova +3 more
doaj +1 more source
Vaginal host–microbe signatures linked to placental outcomes in mares
Equine Veterinary Journal, EarlyView.Abstract Background Ascending placentitis is a leading cause of late‐term pregnancy loss in mares. Although pathogens are presumed to ascend from the caudal reproductive tract, the association between the vaginal microbiome and placentitis has not been systematically examined.
Machteld van Heule +7 more
wiley +1 more source
Frontiers in MicrobiologyIntroductionThe vulvar microbiome is adjacent to that of the skin and the vagina and connects microbiomes present on a stratified epithelial barrier to that of a mucosal barrier.
Arnout Mieremet +5 more
doaj +1 more source
Modern treatment of vulvar cancer
Radiology and Oncology, 2020 Vulvar cancer accounts for 3–5% of malignant diseases of the female genital tract. The Slovenian incidence rate is 5.5/100,000, which means 57 new cases per year. The most common histological type (90%) is squamous cell carcinoma.
Merlo Sebastjan
doaj +1 more source
Laser neoureterocystostomy to treat ectopic ureters
Equine Veterinary Journal, EarlyView.Abstract Background Ureteral ectopia is an uncommon but clinically important congenital abnormality in horses. If left untreated, it can lead to persistent dermatitis, urinary tract infections, and failure to thrive. Surgical correction is necessary, but traditional approaches have produced mixed results with high morbidity.
Caitlin Smith, Eric J. Parente
wiley +1 more source
Genetic variants of EcPV2 E6 and E7 in equine genital and oronasal squamous cell carcinoma
Equine Veterinary Journal, EarlyView.Abstract Background Since its discovery in 2008, equine papillomavirus type 2 (EcPV2) has been detected in up to 100% of equine genital and up to 40% of equine oronasal squamous cell carcinomas (SCCs). Preliminary sequence data point to the existence of EcPV2 E6 and E7 oncogene variants compared to the British reference sequence from 2008.
Maya Jenner, Sabine Brandt
wiley +1 more source
Recurrent vulvar condiloma treatment in infant
DST, 2022 Introduction: Anogenital warts are one of the major clinical manifestations of the Human Papillomavirus (HPV). Case reports in children have grown in the last decades; however, there are still difficulties in determining the virus epidemiology and the ...
Denise Gasparetti Drumond +5 more
doaj
International Journal of Cancer, EarlyView.ABSTRACT Immune checkpoint inhibitors (ICIs) frequently cause thyroid immune‐related adverse events (irAEs). Permanent hypothyroidism, the clinically most relevant phenotype, requires lifelong hormone replacement. We investigated its incidence, course, risk factors, and prognostic relevance under pembrolizumab.
Freya Koffka +9 more
wiley +1 more source
Gynecologic Oncology ReportsThere is limited data regarding the use of immunotherapy for patients with vulvar squamous cell carcinoma and coexisting autoimmune disease. Cemiplimab is a PD-1 inhibitor approved for use in patients with locally advanced and metastatic cutaneous ...
Elizabeth G. Thayer +6 more
doaj +1 more source